These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26813962)

  • 41. Rate of D-alloimmunization in trauma does not depend on the number of RhD-positive units transfused: The BEST collaborative study.
    Seheult JN; Callum J; Delaney M; Drake R; Dunbar NM; Harm SK; Hess JR; Jackson BP; Javanbakht A; Moore SA; Murphy MF; Raval JS; Staves J; Tuott EE; Wendel S; Ziman A; Yazer MH;
    Transfusion; 2022 Aug; 62 Suppl 1():S185-S192. PubMed ID: 35748692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevention of RhD alloimmunization in RhD negative women.
    Lubusky M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2010 Mar; 154(1):3-7. PubMed ID: 20445704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
    Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT
    Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemolytic disease of the fetus and newborn in the molecular era.
    Fasano RM
    Semin Fetal Neonatal Med; 2016 Feb; 21(1):28-34. PubMed ID: 26589360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women.
    Dündar Yenilmez E; Kökbaş U; Kartlaşmış K; Kayrın L; Tuli A
    PLoS One; 2018; 13(6):e0197855. PubMed ID: 29874251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The importance of immunohematology testing in the neonatal period].
    Bujandrić N; Milanović MK
    Med Pregl; 2013; 66(7-8):317-21. PubMed ID: 24069814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland.
    Haimila K; Sulin K; Kuosmanen M; Sareneva I; Korhonen A; Natunen S; Tuimala J; Sainio S
    Acta Obstet Gynecol Scand; 2017 Oct; 96(10):1228-1233. PubMed ID: 28718198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emergency transfusion of patients with unknown blood type with blood group O Rhesus D positive red blood cell concentrates: a prospective, single-centre, observational study.
    Selleng K; Jenichen G; Denker K; Selleng S; Müllejans B; Greinacher A
    Lancet Haematol; 2017 May; 4(5):e218-e224. PubMed ID: 28389344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blood Group Rhesus D-negativity and Awareness Toward Importance of Anti-D Immunoglobulin Among Pregnant Women in Bisha, Saudi Arabia.
    Yahia A; Miskeen E; Sohail SK; Algak T; Aljadran S
    Cureus; 2020 Feb; 12(2):e7044. PubMed ID: 32128293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prospective Evaluation of a Transfusion Policy of RhD-Positive Red Blood Cells into DEL Patients in China.
    Xu W; Zhu M; Wang BL; Su H; Wang M
    Transfus Med Hemother; 2015 Jan; 42(1):15-21. PubMed ID: 25960711
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HIV and Pregnancy: A Retrospective Descriptive Cross-sectional Study of Prevalence, Maternal, Obstetrical, and Neonatal Outcome at a Tertiary Care Hospital in Oman.
    Al Hasani NAS; Al Dughaishi T; Balkhair AA
    Oman Med J; 2021 Nov; 36(6):e321. PubMed ID: 34868667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-D Alloimmunization After RhD Positive Red Cell Transfusion to Selected RhD Negative Patients.
    Pandey P; Setya D; Singh MK
    Indian J Hematol Blood Transfus; 2022 Jul; 38(3):577-584. PubMed ID: 35747571
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rhesus-D zygosity and hemolytic disease of fetus and newborn.
    Moghaddam M; Naghi A; Hassani F; Amini S
    Asian J Transfus Sci; 2013 Jul; 7(2):156-7. PubMed ID: 24014950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RhD negativity among pregnant women in multiethnic Suriname.
    Zonneveld R; Schmitz P; Eppink J; Mac Donald MS; Nahar-van Venrooij LM; Kanhai HH; Zijlmans WC
    Transfusion; 2016 Feb; 56(2):321-4. PubMed ID: 26677093
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer type predicts alloimmunization following RhD-incompatible RBC transfusions.
    Arora K; Kelley J; Sui D; Ning J; Martinez F; Lichtiger B; Tholpady A
    Transfusion; 2017 Apr; 57(4):952-958. PubMed ID: 28191636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of Rh alloimmunization.
    Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
    J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prevention of Rh (D) alloimmunization in Rh (D) negative women in pregnancy and after birth of Rh (D) positive infant].
    L'ubuský M; Procházka M; Krejcová L; Vetr M; Santavý J; Kudela M
    Ceska Gynekol; 2006 May; 71(3):173-9. PubMed ID: 16768042
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Obstetric outcome after RhD and Kell testing.
    Lipitz S; Many A; Mitrani-Rosenbaum S; Carp H; Frenkel Y; Achiron R
    Hum Reprod; 1998 Jun; 13(6):1472-5. PubMed ID: 9688374
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Why do RhD negative pregnant women still become anti-D immunized despite prophylaxis with anti-D immunoglobulin?
    Akkök ÇA
    Transfus Apher Sci; 2024 Jul; 63(4):103969. PubMed ID: 38959811
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.